Summit Therapeutics Inc

NASDAQ:SMMT   4:00:00 PM EDT
2.31
+1.52 (+194.27%)
7:59:59 PM EDT: $2.44 +0.13 (+5.63%)
Earnings Announcements

Summit Therapeutics Reports Third Quarter Financial Results

Published: 11/09/2022 15:36 GMT
Summit Therapeutics Inc (SMMT) - Summit Therapeutics Inc. Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2022.
Summit Therapeutics Inc - Continuing to Perform Ind-enabling Activities for Our Second Drug Candidate, Smt-738.
Summit Therapeutics Inc - Qtrly Loss per Share $0.14.